SCHEMBL18550795

SCHEMBL18550795

Cc1oc2cc(O)ccc2c(=O)c1Oc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 11/20 1.00
▸ KDM4E B2RXH2 9/20 1.00
▸ HPGD P15428 8/20 1.00
▸ GAA P10253 7/20 1.00
▸ GLA P06280 5/20 1.00
▸ HSD17B10 Q99714 5/20 1.00
▸ TSHR P16473 3/20 1.00
▸ KMT2A Q03164 5/20 0.79
▸ MAPT P10636 4/20 0.79
▸ MEN1 O00255 4/20 0.79
▸ THRB P10828 1/20 0.79
▸ HTT P42858 1/20 0.79
▸ MAPK1 P28482 2/20 0.73
▸ TP53 P04637 2/20 0.70
▸ CYP2C9 P11712 2/20 0.67
▸ CYP2C19 P33261 2/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ CASP1 P29466 1/20 0.66
▸ CASP7 P55210 1/20 0.66
▸ NPSR1 Q6W5P4 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12722310 0.85 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL18550800 0.83 ALDH1A1 (0.70) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL18550801 0.82 GAA (0.71) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL18550854 0.82 ALDH1A1 (0.69) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL1626916 0.81 KMT2A (1.00) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL27225472 0.81 LMNA (0.79) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL5266910 0.76 ALDH1A1 (1.00) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL27225557 0.76 KDM4E (0.61) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL3956317 0.75 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDGAAGLA
SCHEMBL14158306 0.74 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDGAAGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11576892-B2 Benzopyran derivatives and uses thereof NOVATION PHARMACEUTICALS INC. (CA) 2023-02-14 — — US disclosed
US-20220016071-A1 BENZOPYRAN DERIVATIVES AND USES THEREOF NOVATION PHARMACEUTICALS INC. (CA) 2022-01-20 — — US disclosed
WO-2017027973-A1 BENZOPYRAN DERIVATIVES AND USES THEREOF NOVATION PHARMACEUTICALS INC. (CA) 2017-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220016071-A1 BENZOPYRAN DERIVATIVES AND USES THEREOF UPF1, EIF2AK2, RPL37A ALDH1A1 1232/4885KDM4E 4147/4885HPGD 420/4885
US-11576892-B2 Benzopyran derivatives and uses thereof UPF1, EIF2AK2, RPL37A ALDH1A1 1232/4885KDM4E 4147/4885HPGD 420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback